agilon health, inc. (NYSE:AGL) Shares Sold by Blair William & Co. IL

Blair William & Co. IL lessened its holdings in agilon health, inc. (NYSE:AGL) by 4.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 231,038 shares of the company’s stock after selling 11,038 shares during the quarter. Blair William & Co. IL owned about 0.06% of agilon health worth $1,511,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of AGL. Quest Partners LLC acquired a new stake in shares of agilon health during the 4th quarter worth approximately $45,000. Neo Ivy Capital Management acquired a new stake in agilon health during the fourth quarter valued at $47,000. J.Safra Asset Management Corp increased its holdings in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its position in shares of agilon health by 31.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock worth $113,000 after acquiring an additional 2,149 shares during the period. Finally, CWM LLC boosted its stake in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares in the last quarter.

agilon health Price Performance

Shares of NYSE:AGL opened at $3.84 on Tuesday. agilon health, inc. has a 52 week low of $3.07 and a 52 week high of $20.37. The company has a 50-day moving average price of $5.11 and a 200 day moving average price of $5.50. The company has a market cap of $1.58 billion, a P/E ratio of -5.48 and a beta of 0.54. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the firm posted ($0.04) EPS. The business’s revenue was up 38.7% compared to the same quarter last year. Research analysts predict that agilon health, inc. will post -0.32 earnings per share for the current year.

Insider Activity

In other agilon health news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.20% of the company’s stock.

Analyst Upgrades and Downgrades

AGL has been the subject of several research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Evercore ISI lifted their target price on shares of agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research report on Tuesday, July 9th. Robert W. Baird began coverage on shares of agilon health in a research report on Thursday, May 30th. They set a “neutral” rating and a $6.00 price target for the company. Baird R W upgraded agilon health to a “hold” rating in a report on Thursday, May 30th. Finally, Benchmark reissued a “buy” rating and set a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, agilon health has a consensus rating of “Hold” and an average target price of $8.57.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.